Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

Growth is being driven by the increased adoption of IoT and AI in industrial environments, which enhance productivity, efficiency, and real-time decision-making. However, high initial capital ...

The directive follows the Trump administration’s broader agenda to gut efforts to document and address climate change.

The entry into force of the Regulation on the European Health Data Space (EHDS) is seen by many as a milestone for healthcare ...

The Senate confirmed two of President Donald Trump’s health nominees Tuesday evening, largely along party lines, in a win for ...

EQS-News: Newron Pharmaceuticals S.p.A. / Key word (s): Personnel Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman ...

Artificial Intelligence (AI) has leapt from sci-fi to real-world with incredible speed. But sorting through AI's noisy, hype-filled landscape to find valuable use cases requires both a discerning ...

Today, we are a public company listed on the Nasdaq exchange under our new parent company name, Wellgistics Health, Inc. (NASDAQ: WGRX), we have completed several acquisitions that broaden our service ...

The RIT Cyber Range and Training Center delivers a unique training experience for corporate leaders and IT security professionals. Our cutting-edge technology allows us to create realistic threat ...

(2005). Os resultados foram analisados por meio de análise de variância, utilizando-se o PROC GLM do programa computacional SAS (User s... 2002). Utilizou-se o teste de Tukey para comparação das ...

With something for everyone – adults, children and the whole family – discover science directly from the minds of the world’s leading scientists and thinkers.